By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Galapagos NV 

Industriepark Mechelen Noord I, Zone L
Generaal De Wittelaan 11 A
Mechelen    B-2800  Belgium
Phone: 32-15-34-29-00 Fax: 32-15-34-29-01



Company News
Galapagos (GLPG.BR) Increases Share Capital Through Warrant Exercises 11/30/2016 9:42:39 AM
Galapagos (GLPG.BR) Initiates Phase 1 Study With Cystic Fibrosis Drug GLPG2737 11/29/2016 10:02:42 AM
Galapagos (GLPG.BR) Release: Phase 3 Study With Filgotinib Initiated In Crohn's Disease 11/23/2016 1:49:44 PM
Galapagos (GLPG.BR) Release: Robust Progress In Q3 2016 10/28/2016 8:59:13 AM
Galapagos (GLPG.BR) To Present Progress In CF Programs At NACFC 2016 10/27/2016 9:20:17 AM
Galapagos (GLPG.BR) Release: Transparency Notification - FMR LLC Reaches 10% Threshold 10/13/2016 10:11:33 AM
MorphoSys AG And Galapagos (GLPG.BR) Start First-In-Patient Dosing of IL-17C Antibody MOR106 In Atopic Dermatitis 9/29/2016 9:22:32 AM
Galapagos (GLPG.BR) Release: Successful Completion Of Regulatory Consultations To Progress Filgotinib To Phase 3 In Inflammatory Bowel Disease 9/28/2016 1:11:09 PM
Gilead (GILD) Can’t Buy Belgium’s Galapagos (GLPG.BR)—Yet 9/28/2016 5:51:40 AM
Galapagos (GLPG.BR) Release: Endoscopic Improvements With Filgotinib Are Consistent With Clinical Remission Rates In Patients With Crohn's Disease 9/26/2016 9:36:44 AM